Blood neurofilament light levels segregate treatment effects in multiple sclerosis

OBJECTIVE: To determine factors (including the role of specific disease modulatory treatments [DMTs]) associated with (1) baseline, (2) on-treatment, and (3) change (from treatment start to on-treatment assessment) in plasma neurofilament light chain (pNfL) concentrations in relapsing-remitting mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Delcoigne, Bénédicte, Manouchehrinia, Ali, Barro, Christian, Benkert, Pascal, Michalak, Zuzanna, Kappos, Ludwig, Leppert, David, Tsai, Jon A., Plavina, Tatiana, Kieseier, Bernd C., Lycke, Jan, Alfredsson, Lars, Kockum, Ingrid, Kuhle, Jens, Olsson, Tomas, Piehl, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387108/
https://www.ncbi.nlm.nih.gov/pubmed/32047070
http://dx.doi.org/10.1212/WNL.0000000000009097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387108/
https://www.ncbi.nlm.nih.gov/pubmed/32047070
http://dx.doi.org/10.1212/WNL.0000000000009097

Ejemplares similares